Riju Jeyashanth, Thomas Nihal, Paul Thomas V, Abraham Deepak Thomas, Pai Rekha, Prabhu Anne J, Jacob Paul Mazhuvanchary, Rajan Remya, Michael Rajiv C, Tirkey Amit Jiwan, Ramalingam Natarajan, Asha Hesarghatta S, Kapoor Nitin
Department of Head and Neck Surgery, Christian Medical College, Vellore, Tamil Nadu, India.
Department of Endocrinology Diabetes and Metabolism, Christian Medical College, Vellore, Tamil Nadu, India.
Indian J Endocrinol Metab. 2024 Jan-Feb;28(1):3-10. doi: 10.4103/ijem.ijem_415_23. Epub 2024 Feb 26.
The increased detection of thyroid nodules in the human population has led to an increase in the number of thyroid surgeries without an improvement in survival outcomes. Though the choice for surgery is straightforward in malignant thyroid nodules, the decision is far more complex in those nodules that get categorized into indeterminate thyroid nodules (ITN) by fine needle aspiration. Therefore, there is a pressing need to develop a tool that will aid in decision-making among the ITN. In this context, the development of various molecular testing (MT) panels has helped to confirm or rule out malignancy, reducing unnecessary surgeries and potentially guiding the extent of surgery as well. Currently, such tests are widely used among the Western population but these MT panels are not used by the South Asian population because of non-availability of validated panels and the high cost involved. There is a need to develop a suitable panel which is population-specific and validate the same. In this review, we would focus on current trends in the management of ITN among the South Asian population and how to develop a novel MT panel which is cost-effective, with high diagnostic accuracy obviating the need for expensive panels that already exist.
人群中甲状腺结节检出率的增加导致甲状腺手术数量上升,但生存结果并未改善。虽然对于恶性甲状腺结节,手术选择很明确,但对于那些通过细针穿刺被归类为不确定甲状腺结节(ITN)的结节,决策要复杂得多。因此,迫切需要开发一种有助于ITN决策的工具。在这种背景下,各种分子检测(MT) panel的开发有助于确认或排除恶性肿瘤,减少不必要的手术,并可能指导手术范围。目前,此类检测在西方人群中广泛使用,但由于缺乏经过验证的panel以及成本高昂,南亚人群并未使用这些MT panel。有必要开发一种适合特定人群的panel并进行验证。在本综述中,我们将关注南亚人群中ITN管理的当前趋势,以及如何开发一种具有成本效益、诊断准确性高的新型MT panel,从而无需使用现有的昂贵panel。